Slide 1: HY 2020 Results Presentation
pro+medicus OUR SUPPORT. YOUR SUCCESS. HY 2020 RESULTS PRESENTATION February 2020 VISAGE IMAGING:
Slide 2: Pro Medicus
PRO MEDICUS (ASX:PME) Healthcare IT company specializing in Enterprise Imaging and Radiology Information System (RIS) software. Leading edge products, growing global presence. EU HQ/R&D Berlin GmbH U.S. HO San Diego CA wd GROUP HO Melbourne AUS % VISAGE TMAGING" 2
Slide 3: Visage RIS Product Suite
VISAGE RIS ©) ASX:PME pro+medicus.net @B VISAGE? Pd | OEM VISAGE 7 OEM PRODUCT SUITE prosmedicu % ners ie, Visace IMAGING:
Slide 4: Visage RIS
@ VISAGERIS TECHNOLOGIST DOCTOR TRANSCRIPTIONIST. SEARCH CLAIMING — SETUP. Recent|¥ Dr RSimpson |v /+ ‘Appointments Northern Book ‘Visage General Hospital 4 Tue, 17-0cr201 MTP” @ Patient © Procedure [Cancelled Blocked Visage Xray ~ Visage US Room ~ Visage US Room 2 ~ ssn (Visage US Room3 + Visage Ma
Slide 5: Long term contracts with Primary Healthcare and I-MED
y VV VISAGE RIS Long term (5 year) contracts with Primary Healthcare and @ VISAGE RIS |-MED, the 2 biggest radiology providers in AUS Radiology prehensive care, Uncompromising auality, Combined additional revenue of $4.4M pa once fully deployed cay saa “MED Network Rollouts progressing well Potentia
Slide 6: Leading Edge Platform
LEADING EDGE PLATFORM Visage 7 continues to be #1 in Speed, Functionality and Scalability. SPEED FUNCTIONALITY SCALABILITY prosmedicus 4 cue sueromr your suas VISAGE TMAGING*
Slide 7: Massive Data Explosion
MASSIVE DATA EXPLOSION ¢ High density Multi-slice CT - 10,000+ images ¢ HD Breast Tomosynthesis - 6 GB+ ¢ (Optoacoustic breast ultrasound - 10+ GB ¢ Total Body PET Scan - 10+ GB ¢ 7T MRI - much larger than 3T % VISAGE TMAGING"
Slide 8: Legacy Technology "Compress and Send"
4 vv LEGACY TECHNOLOGY 4 “Compress and Send" V MODALITIES PACS RADIOLOGIST/CLINICIAN prosmedicus 4 founsupront your success VISAGE IMAGING’
Slide 9: Solution: Visage 7 Streaming Technology
A YY SOLUTION: 4 & VISAGE 7? Streaming Technology RADIOLOGIST/CLINICIAN 7 BACKEND RENDER %) SERVER SERVER 7 A prosmedicus 4 founsupront your success VISAGE IMAGING’
Slide 10: In Review HY 2020
In Review HY 2020 a] FFB THE OHIO STATE rN Nines PARTNERS Ae UNIVERSITY HEALTHCARE — _») WEXNER MEDICAL CENTER Implementation VISAGE CLOUD PLATFORM $9M/5 years $6M/5 years completed in Highly Continues to grow New Contract New Contract record time Optimised STRONGLY t t t + + NOVEMBER 2019 DECEMBER
Slide 11: Results HY 2020
RESULTS HY 2020 $29.3M $12.1M $14.81M 50.2% Revenue Profit 0 Underlying EBIT S up 15.7% S ns er % sae margins ae ee eee ee $38.8M $0.06 Cash Company Strong Fully franked Reserves debt balance Interim up 20.2% free sheet dividend up 71.4% prosmedicus % VISAGE TMAGING"
Slide 12: 1H v 2H Revenue Split
$35,000,000 1H v 2H revenue split Exam/licence revenue*** Support/baseline revenue*** Capital revenue (net of hardware) Professional Services*** ***Recurring revenue $30,000,000 $2,373,000 $25,000,000 $2,649,000 $3,815,000 $7,603,000 $20,000,000 $3,049,000 $6,092,000 $3,246,000 $15,000,000 $905,000
Slide 13: Operational (Transaction) Model
y OPERATONAL (TRANSACTION) MODEL Used in vast majority of US contracts Delivered as SaaS model Now used in RIS contracts in AUS Model based on quaranteed transaction minimums Forward revenue > AS195M/5 years* Upside as client examination volumes grow Annuity style revenue stream — greater predictabi
Slide 14: Exam (Transaction) Revenue
YY EXAM (TRANSACTION) REVENUE / 9 ¢ Recurring in nature ° Increased by 30% HoH * Growth to continue for FY 2020 (Partners, Duke, OSU & others) * Growth from existing clients (organic and M&A) plus new clients : ¢ Further upside with adoption of new products A (VISAGE 7 Open Archive and Enterprise Im
Slide 15: Professional Services
A VV PROFESSIONAL SERVICES Vv ¢ Project planning, training & implementation -—————— [ol * Revenue spread over the length of the contract Q A - new accounting standards (AASB 15) L ° Recurring in nature ~ 10% contract value oo i } e Will decrease as a % of total revenue as exam 0 y (transaction) reve
Slide 16: Operating Leverage
OPERATING LEVERAGE * No capex (HW) - SW only model ° Training & Installation - charged as professional services ¢ Highly scalable offering ed ) * Contained cost base * High operating leverage ¢ Margin continues to grow as footprint increases Ce $$ prosmedicus | % founsupront your success VISAGE IMA
Slide 17: Ohio State University Wexner Medical Center
7 YY’ OHIO STATE UNIVERSITY 6 Wexner Medical Center ¢ Minimum o illion over 5 years v Minimum of $9 Milli 5 A: Transaction-based licensing model with upside A ¢ Large regional hospital system * Teaching hospital for The Ohio State College of Medicine y ¢ Implementation scheduled for Q4 FY20 VV A A p
Slide 18: Nines
NINES ° 5 year - $6 Million platform deal ¢ Transaction based model - volumes to step up YoY * SaaS offering based on Visage in the Cloud (Google) ° Nines team — highly respected in machine learning, Al, and radiology circles ¢ Leveraging the power of modern Al to clinical settings * Opens up new ma
Slide 19: Fast Track Implementation
FAST TRACK IMPLEMENTATION ¢ Allimplementations on or ahead of schedule ¢ Fast track methodology continues to deliver ¢ Large scale projects completed in under 1/4 the time of industry norm ¢ Delivers huge savings for client ¢ Frees PME staff for other jobs ° Reduces barrier to change ¢ A key differe
Slide 20: Visage Proven ROI
: % ry VISAGE - PROVEN ROI VisAce IMAGING: >. Significant IT & Unparalleled Increase in Greater Clinical Infrastructure Savings Radiologist Efficiency Accuracy Vv Improved Physician Delivers Superior y Engagement Value Proposition prosmedicus | 4 founsupront your success VISAGE IMAGING’ 20
Slide 21: Growth Strategy
GROWTH STRATEGY New product offerings Transaction growth Extend to new from existing clients geographical markets Leverage R&D capability to introduce next generation products Expand footprint - s r VV 4 7 y Vv new clients ay A A My A : i y cum supPoRT Youn suBezss | VISAGE IMAGING" 21
Slide 22: Progressing through the Cycle
© Prospects y © Progressing through V Network Effect various stages } of the cycle Increased as a result of recent high- profile wins A Opportunities A last 12 months - significant increase in number of inbound RFPs Pipeline Robust In terms of quality and quantity of opportunities prosmedicus | 4 fo
Slide 23: New Products: Visage 7 Open Archive
A NEW PRODUCTS vv 4 VISAGE ? OPEN ARCHIVE ¢ Same highly scalable enterprise imaging platform used in VISAGE 7 ¢ — Interoperable - works in complex environments ¢ — Enables Visage to offer choice of A modular or single vendor solutions A ¢ Pipeline includes opportunities for = Viewer and Visage Open
Slide 24: New Products: Enterprise Imaging
VV NEW PRODUCTS ENTERPRISE IMAGING VISAGE 7 Al ¢ — Single viewer for ALLimages in the medical record (EMR) * — Radiology/Cardiology (DICOM format) ENCOUNTER ¢ Non-radiology- reflected light - v hi-res photos & videos 7 a ¢ VISAGE 7 technology ideally suited / A * Increases Visage value proposition o
Slide 25: Visage Worklist
Visage ? WORKLIST Adds to V? Viewer and Archive modules Based on over 30 years experience in Worklist SW Allows PME to offer single vendor solution if required Integral part of Visage in the Cloud SaaS solution Ability to interface with broad range of Al algorithms prosmedicu ners ie, Visace IMAGING
Slide 26: Visage in the Cloud
VISAGE in the CLOUD ¢ Visage 7 - highly optimised for Cloud deployment ¢ Same Ultrafast performance as on premise ¢ Full Visage 7 functionality ¢ Security and scale of the cloud * Full deployment or as backup/disaster recovery ¢ Suitable for all size implementations ¢ Opens up new market opportuniti
Slide 27: Visage Accelerator
Visage / N ACCELERATOR ¢ Unique end to end solution ¢ Supports both research and production environments ona single platform ¢ Based on market leading Visage 7 technology ¢ Enables Visage clients to fast track Al as part of their imaging strategy prosmedicus % ners ie, Visace IMAGING: 27
Slide 28: Visage Accelerator
Visage / N ACCELERATOR e Visage Research Server - streamlines Al algorithm development * Optimised for Al data curation and validation * Open API - seamless integration ¢ Al Ecosystem - 3" party and Visage developed algorithms * Joint development/commercialisation opportunities - 3 parties and acade
Slide 29: AI Research Leadership
A Ww . Al Research Leadership \ ACCELERATOR ¢ & Malte Westerhoff Chief Technology Officer Vv 7 ‘2 Detlev Stalli y r a aun 4 w ; ; \ Ming De Lin Clinical Research Manager North America X — prosmedicu | ners ie, Visace IMAGING: 29
Slide 30: Breast Density - AI
YY Breast Density - Al . i 4s . ACCELERATOR ¢ st diagnostic Al algorithm produced by Visage ¢ Developed in collaboration with renown breast imaging team at Yale \ + Provides “on the fly” Al assessment of breast density ) e Previewed at RSNA 2019 as WIP é ¢ A model for future collaboration with other
Slide 31: Summary
4 YY SUMMARY f * Growing North American footprint ¢ Transaction revenue up 30% compared to 2nd Half FY2019 ¢ Market leading technologies v A. Growin g product portfolio A ¢ Proven implementation & support capability ¢ Unparalleled value proposition (Clinical and Financial RO!) ye er . ¢ Pipeline Con
Slide 32: a) f=) > << = <o - kt
a) f=) > << = <o - kt